OREX up +27.27% percent right now. $OREX High is at 4.88

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 2:34 PM

OREX up +27.27% percent right now. $OREX High is at 4.88 and the Low 4.04 with current volume of 5,295,252.

Recent News posted below.

OREX Orexigen Therapeutics Recent Headline News

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - 1 hr 9 mins ago

OREX: 5.03 (+1.18), VVUS: 3.25 (-0.08), ARNA: 4.31 (+0.05)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - 1 hr 34 mins ago

UCP: 11.96 (-1.83), JRJC: 6.16 (+0.65), NAVB: 1.02 (-0.20), SANW: 3.81 (+0.73), PLPM: 1.62 (+0.25), RYN: 28.85 (-5.05), INFU: 3.01 (-0.48), LIOX: 5.47 (+0.73), DY: 27.85 (-3.02), MTZ: 25.17 (-3.46), CGIX: 6.95 (+0.95), MUX: 1.25 (-0.16), OREX: 5.03 (+1.18), URRE: 2.60 (+0.66), ACHN: 12.61 (+2.50), REN: 2.86 (-0.75), MPO: 3.41 (+0.30), AKBA: 9.35 (-1.35), TRX: 1.02 (-0.20), PLNR: 7.60 (+1.20)

Stock to Watch: Orexigen Therapeutics Up 19.5% (OREX)
Comtex SmarTrend(R) - 2 hrs 6 mins ago
Orexigen Therapeutics (NASDAQ:OREX) is one of today's best performing low-priced stocks, up 19.5% to $4.60 on 1.1x average daily volume. Orexigen Therapeutics has traded 3.6 million shares thus far today, vs. average volume of 3.3 million shares per day. The stock has outperformed the Dow (19.5% to the Dow's 0.1%) and outperformed the S&P 500 (19.5% to the S&P's 0.3%) during today's trading.
OREX: 5.03 (+1.18)

Orexigen Therapeutics' (OREX) CEO Mike Narachi on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - 2 hrs 42 mins ago

OREX: 5.03 (+1.18)

Orexigen ups earnings by 161% in Q3
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:16AM CST

OREX: 5.03 (+1.18)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.03 (+1.18), VVUS: 3.25 (-0.08), ARNA: 4.31 (+0.05)

Orexigen Therapeutics (OREX) Stock Soars Today on Big Third Quarter Earnings Beat
at The Street - Mon Nov 10, 9:33AM CST
Orexigen Therapeutics (OREX) stock is skyrocketing this morning after the company posted higher than expected third quarter earnings.
OREX: 5.03 (+1.18)

Orexigen Beats The Street On Milestone Payments
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 8:21AM CST

OREX: 5.03 (+1.18)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:14AM CST

PT: 1.63 (+0.11), GPRO: 76.07 (-2.99), OREX: 5.03 (+1.18), GOGO: 18.10 (+1.46), JRJC: 6.16 (+0.65), UEC: 1.87 (+0.15), ACHN: 12.61 (+2.50), ARQL: 1.15 (+0.09), CMCM: 20.66 (+0.46), IBIO: 1.23 (+0.07), DF: 16.26 (+1.84)

Orexigen Therapeutics (OREX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 7:25AM CST

OREX: 5.03 (+1.18)

Orexigen Therapeutics beats by $0.22, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:08AM CST

OREX: 5.03 (+1.18)

Orexigen Therapeutics Reports Results for the Third Quarter Ended September 30, 2014
PR Newswire - Mon Nov 10, 6:00AM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced results for the third quarter ended September 30, 2014.
OREX: 5.03 (+1.18)

Critical Alerts For Stratasys, Orexigen Therapeutics, YY, Workday and Hong Kong Television Network Released By InvestorsObserver
PR Newswire - Fri Nov 07, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for SSYS, OREX, YY, WDAY and HKTV.
OREX: 5.03 (+1.18), YY: 82.08 (+2.58), WDAY: 95.30 (+0.74), SSYS: 104.60 (+1.53), HKTV: 11.11 (+0.24)

Orexigen Therapeutics to Present at the Credit Suisse Healthcare Conference
PR Newswire - Thu Nov 06, 3:30PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Credit Suisse Healthcare Conference in Phoenix. The presentation is scheduled for Tuesday, November 11th at 2:00 p.m. Mountain Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.
OREX: 5.03 (+1.18)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.03 (+1.18), VVUS: 3.25 (-0.08), ARNA: 4.31 (+0.05)

Orexigen Therapeutics to Host Third Quarter 2014 Financial Results Conference Call and Webcast
PR Newswire - Tue Nov 04, 3:15PM CST
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) will announce financial results for the third quarter 2014, on Monday, November 10, 2014 before markets open. The announcement will be followed by a live webcast and conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific time).
OREX: 5.03 (+1.18)

Orexigen's Contrave Has Modest Start
Spencer Osborne - at Seeking Alpha - Mon Nov 03, 12:30PM CST

OREX: 5.03 (+1.18), ARNA: 4.31 (+0.05)

Orexigen Announces Contrave® (naltrexone HCI and bupropion HCI extended release) Data Presentations at the ObesityWeek Meeting in Boston
PR Newswire - Fri Oct 31, 7:30AM CDT
Orexigen Therapeutics (NASDAQ: OREX) today announced three Contrave® (naltrexone HCI and bupropion HCI) and two disease awareness abstracts have been accepted for poster presentations at the upcoming ObesityWeek meeting. This meeting will be held November 2-7, 2014 in Boston at the Boston Convention and Exposition Center.
OREX: 5.03 (+1.18)

Orexigen Therapeutics Has Substantial Upside For Bull Investors
L&F Capital Management - at Seeking Alpha - Wed Oct 29, 7:27AM CDT

OREX: 5.03 (+1.18)

Arena Skimps on Data Disclosure From Weight-Loss Combo Study
at The Street - Wed Oct 29, 6:30AM CDT
Arena Pharmaceuticals provided very little useful information Tuesday night about the Belviq-phentermine weight-loss combination.
OREX: 5.03 (+1.18), ARNA: 4.31 (+0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TriStar Bank Community Room: A Space for Growth

Building Bridges Through Community Investment Well, ain't this something? Columbia, Tennessee, just got a splash of fresh air. We're talking about the new Southern Regional Technology Center nested in Columbia State Community College. Now, the name on everyone's lips? The TriStar Bank Community Room. But it ain't just about a name plastered up on a wall inside a shiny...

Postal Service Defends New Rule Amid Speculation

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Primero Gains Global Edge with Win Systems Buy

Here's the move: Primero Games, the U.S.-based gaming maestro, just grabbed a hefty piece of the puzzle with their acquisition of Win Systems' Gaming Division. Not two companies merging into obscurity, but a strategic maneuver aiming to scatter new seeds in Latin America and the Caribbean with over 3,000 gaming positions primed and ready. What's in the Pot? You've got...

Penetron Strengthens Midwest, Central USA Support Team

Expansion of Penetron's Engineering Support Eyes are on the Midwest and Central USA as Penetron makes a strategic move to bolster their technical support dream team. They've snagged Sean Allison, a heavyweight with more than three decades' worth of grit and know-how from the construction battlefield. Sean, now stationed in the heart of America's Dairyland—Green Bay,...

Powder River Crude's Open Season: Strategic Move

Powder River Crude Services Drives Into Wyoming Every now and then, a player's got to lay down their cards early, and Powder River Crude Services is doing just that with their open season announcement. Anyone keeping an eye on the crude oil transport game will want to watch how this proposed pipeline project unfolds. Slated to stretch from Converse County to Douglas,...

AEON's AI-Powered Agentic Checkout: A Game Changer?

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

York Space Systems Faces Class Action Headwinds

York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...

Chris Auffenberg Buick: 1.9% APR Drives New Deals

New Financing Options in Carbondale In a world where financing a car sometimes feels like predicting the weather—unreliable and erratic—Chris Auffenberg Buick is turning the tables down in Carbondale with a refreshing approach. They're trotting out a 1.9% APR financing option for those Buick lovers who qualify, all through GM Financial. It's the kind of deal that...

MongoDB Preps for Key September Investor Conferences

Gearing Up for September: MongoDB Targets Investors Folks in the investing world, circle some dates on your calendars. MongoDB, Inc. (NASDAQ: MDB) is taking the stage at three separate investor conferences this September. Why should we care? Because these are not just any old gigs—it's big names like Citi, Goldman Sachs, and Piper Sandler, and they happen to be perfect...

Dahua Dives Deep into AIoT at IFA Berlin 2026

Dahua's AIoT Vision Unfolds in Berlin Forget the coffee runs and the all-too-dry boardroom discussions—Dahua Technology has taken the stage at IFA Berlin 2026 and they're not just singing the same old tune. They're blasting through innovation barriers with a mix of AIoT—the next-gen tech cocktail everyone’s buzzing about. Leveraging AIoT might sound like...